Inclusion of Underrepresented Groups in Preclinical Alzheimer Disease Trials—Opportunities Abound-Reference-Cited by-同舟云学术

Inclusion of Underrepresented Groups in Preclinical Alzheimer Disease Trials—Opportunities Abound

Published:2021-07-06 Issue:7 Volume:4 Page:e2114606
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Manly Jennifer J.¹,Gilmore-Bykovskyi Andrea²,Deters Kacie D.³

Affiliation:

1. Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Department of Neurology, Columbia University Irving Medical Center, New York, New York

2. School of Nursing, University of Wisconsin–Madison, Madison

3. Department of Neuroscience, University of California San Diego, La Jolla

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2781626/manly_2021_ic_210124_1624563427.58237.pdf

Reference6 articles.

1. Association of factors with elevated amyloid burden in clinically normal older individuals.;Sperling;JAMA Neurol,2020

2. Biomarkers for Alzheimer dementia in diverse racial and ethnic minorities—a public health priority.;Barnes;JAMA Neurol,2019

3. Disparities by race and ethnicity among adults recruited for a preclinical Alzheimer disease trial.;Raman;JAMA Netw Open,2021

4. Association between enrollment factors and incident cognitive impairment in Blacks and Whites: data from the Alzheimer’s Disease Center.;Gleason;Alzheimers Dement,2019

5. Generalizability of findings from a clinical sample to a community-based sample: A comparison of ADNI and ARIC.;Gianattasio;Alzheimers Dement,2021

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reasons for undergoing amyloid imaging among diverse enrollees in the A4 study;Alzheimer's & Dementia;2024-07-23

2. Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population‐based study;Alzheimer's & Dementia;2024-05-16

3. Extracellular Vesicles for Alzheimer’s Disease and Dementia Diagnosis;2024-04-24

4. Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial;Alzheimer's & Dementia;2024-04-17

5. Underrepresented and Underserved Populations in Neurological Research;Seminars in Neurology;2024-03-14